DISCO Pharmaceuticals announces final close of EUR 36 million seed financing.

In English

Swiss Life Asset Managers acquires GHZ Gewerbe- und Handelszentrum Schlieren AG

In English
Auf Deutsch

Mabylon AG Initiates Phase I Clinical Trial for the Treatment of Peanut Allergy

In English
Auf Deutsch

AL-S Pharma Reports Positive Results from Phase 2 Study

In English
Auf Deutsch

Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial

In English